Skip to search formSkip to main contentSkip to account menu

HS6ST2 gene

Known as: HEPARAN SULFATE 6-O-SULFOTRANSFERASE 2, HS6ST2, Heparan Sulfate 6-O-Sulfotransferase 2 Gene 
This gene plays a role in the modification of heparan sulfate.
National Institutes of Health

Related topics

Related topics

2 relations
HS6ST2 protein, humanHeparan Sulfate Biosynthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A HS6ST2 gene variant associated with X‐linked intellectual disability and severe myopia in two male twins
X‐linked intellectual disability (XLID) refers to a clinically and genetically heterogeneous neurodevelopmental disorder, in… 
2017
2017
Overexpression of HS6ST2 is associated with poor prognosis in patients with gastric cancer.
The purpose of the present study was to investigate the clinical significance of the expression of heparan sulfate 6-O… 
2015
2015
Overexpression of heparan sulfate 6-O-sulfotransferase-2 enhances fibroblast growth factor-mediated chondrocyte growth and differentiation.
In our previous study, we reported that heparan sulfate 6-O-sulfotransferase‑2 (HS6ST2) plays an important role in the cartilage… 
2012
2012
Abstract 4533: Characteristics of HS6ST2 expression in colorectal cancer
Background. We have found that the gene expression of heparin sulfate D-glucosaminyl 6-O-sulfotransferase-2 (HS6ST2) is… 
2012
2012
Angiogenesis , Metastasis , and the Cellular Microenvironment Heparin-like Polysaccharides Reduce Osteolytic Bone Destruction and Tumor Growth in a Mouse Model of Breast Cancer Bone Metastasis
TGF-b regulates several steps in cancermetastasis, including the establishment of bonemetastatic lesions. TGF-b is released from… 
2012
2012
Dissecting the molecular mechanisms of breast cancer bone metastasis for therapeutic targeting
Breast cancer that has metastasized to bone is currently an incurable disease, causing significant morbidity and mortality. The… 
2011
2011
Abstract 845: Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Transforming growth factor β (TGF-β) is a key regulator… 
2007
2007
Chemotherapeutics: Lethal and resistant partners
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)